These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38247402)

  • 1. A 6-year experience of Zephyr endobronchial valves for severe emphysema in an Australian single-centre cohort.
    Brown MV; Badiei A; Jersmann H; Fon A; Chew CG; Lorraine B; Nguyen P
    Intern Med J; 2024 Jun; 54(6):871-881. PubMed ID: 38247402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bronchoscopic Lung Volume Reduction with Endobronchial Zephyr Valves for Severe Emphysema: A Systematic Review and Meta-Analysis.
    Labarca G; Uribe JP; Pacheco C; Folch E; Kheir F; Majid A; Jantz MA; Mehta HJ; Patel N; Herth FJF; Fernandez-Bussy S
    Respiration; 2019; 98(3):268-278. PubMed ID: 31117102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Zephyr Endobronchial Valves on Dyspnea, Activity Levels, and Quality of Life at One Year. Results from a Randomized Clinical Trial.
    Dransfield MT; Garner JL; Bhatt SP; Slebos DJ; Klooster K; Sciurba FC; Shah PL; Marchetti NT; Sue RD; Wright S; Rivas-Perez H; Wiese TA; Wahidi MM; Goulart de Oliveira H; Armstrong B; Radhakrishnan S; Shargill NS; Criner GJ;
    Ann Am Thorac Soc; 2020 Jul; 17(7):829-838. PubMed ID: 32223724
    [No Abstract]   [Full Text] [Related]  

  • 4. Endobronchial Valve Treatment in Emphysema Patients with a Very Low DLCO.
    van Dijk M; Hartman JE; Klooster K; Ten Hacken NHT; Kerstjens HAM; Slebos DJ
    Respiration; 2020; 99(2):163-170. PubMed ID: 31962325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Multicenter Randomized Controlled Trial of Zephyr Endobronchial Valve Treatment in Heterogeneous Emphysema (TRANSFORM).
    Kemp SV; Slebos DJ; Kirk A; Kornaszewska M; Carron K; Ek L; Broman G; Hillerdal G; Mal H; Pison C; Briault A; Downer N; Darwiche K; Rao J; Hübner RH; Ruwwe-Glosenkamp C; Trosini-Desert V; Eberhardt R; Herth FJ; Derom E; Malfait T; Shah PL; Garner JL; Ten Hacken NH; Fallouh H; Leroy S; Marquette CH;
    Am J Respir Crit Care Med; 2017 Dec; 196(12):1535-1543. PubMed ID: 28885054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimal important difference of target lobar volume reduction after endobronchial valve treatment for emphysema.
    Welling JBA; Hartman JE; van Rikxoort EM; Ten Hacken NHT; Kerstjens HAM; Klooster K; Slebos DJ
    Respirology; 2018 Mar; 23(3):306-310. PubMed ID: 28913877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bronchoscopic lung volume reduction with endobronchial valves for patients with heterogeneous emphysema and intact interlobar fissures (the BeLieVeR-HIFi study): a randomised controlled trial.
    Davey C; Zoumot Z; Jordan S; McNulty WH; Carr DH; Hind MD; Hansell DM; Rubens MB; Banya W; Polkey MI; Shah PL; Hopkinson NS
    Lancet; 2015 Sep; 386(9998):1066-73. PubMed ID: 26116485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endobronchial Valve Therapy in Patients with Homogeneous Emphysema. Results from the IMPACT Study.
    Valipour A; Slebos DJ; Herth F; Darwiche K; Wagner M; Ficker JH; Petermann C; Hubner RH; Stanzel F; Eberhardt R;
    Am J Respir Crit Care Med; 2016 Nov; 194(9):1073-1082. PubMed ID: 27580428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung volume reduction for emphysema using one-way endobronchial valves: An Australian cohort.
    Sidhu C; Wilsmore N; Shargill N; Rangamuwa K
    Medicine (Baltimore); 2023 Aug; 102(31):e34434. PubMed ID: 37543787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline regional perfusion impacts exercise response to endobronchial valve therapy in advanced pulmonary emphysema.
    Argula RG; Strange C; Ramakrishnan V; Goldin J
    Chest; 2013 Nov; 144(5):1578-1586. PubMed ID: 23828481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of simultaneous combined Zephyr and Spiration valve therapy in patients with advanced pulmonary emphysema.
    Dittrich AS; Kontogianni K; Unterschemmann AS; De Rossi S; Trudzinski F; Brock JM; Gompelmann D; Heussel CP; Herth FJF; Eberhardt R
    Respir Med; 2024 Nov; 233():107760. PubMed ID: 39098557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of the 9-mm Intrabronchial Valve in Patients with Advanced Emphysema.
    Kontogianni K; Gompelmann D; Valipour A; Gerovasili V; Schuhmann M; Stanzel F; Herth FJF; Eberhardt R
    Respiration; 2020; 99(4):333-343. PubMed ID: 32311695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoscopic Lung Volume Reduction Using Endobronchial Valves in Patients with Severe Emphysema and Very Low FEV1.
    Trudzinski FC; Höink AJ; Leppert D; Fähndrich S; Wilkens H; Graeter TP; Langer F; Bals R; Minko P; Lepper PM
    Respiration; 2016; 92(4):258-265. PubMed ID: 27603781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The minimal important difference for target lobe volume reduction after endoscopic valve therapy.
    Gompelmann D; Kontogianni K; Schuhmann M; Eberhardt R; Heussel CP; Herth FJ
    Int J Chron Obstruct Pulmon Dis; 2018; 13():465-472. PubMed ID: 29440884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-Year Follow-Up after Endobronchial Valve Treatment in Patients with Emphysema without Collateral Ventilation Treated in the STELVIO Trial.
    Klooster K; Hartman JE; Ten Hacken NH; Slebos DJ
    Respiration; 2017; 93(2):112-121. PubMed ID: 27974713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved exercise capacity results in a survival benefit after endobronchial valve treatment.
    Roodenburg SA; Slebos DJ; van Dijk M; Koster TD; Klooster K; Hartman JE
    Respir Med; 2023; 210():107175. PubMed ID: 36858325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical review: Endobronchial valve treatment for emphysema.
    Jarad N
    Chron Respir Dis; 2016 May; 13(2):173-88. PubMed ID: 26879696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bronchoscopic Lung Volume Reduction with Valves and Coils. A Network Meta-analysis.
    Iftikhar IH; Schimmel M; Sardi A; Mehta I; Gonzalez E; Musani AI
    Ann Am Thorac Soc; 2020 Nov; 17(11):1468-1475. PubMed ID: 32574516
    [No Abstract]   [Full Text] [Related]  

  • 19. Endobronchial Valve (Zephyr) Treatment in Homogeneous Emphysema: One-Year Results from the IMPACT Randomized Clinical Trial.
    Eberhardt R; Slebos DJ; Herth FJF; Darwiche K; Wagner M; Ficker JH; Petermann C; Hübner RH; Stanzel F; Shargill NS; Valipour A;
    Respiration; 2021; 100(12):1174-1185. PubMed ID: 34350884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Multicenter Randomized Controlled Trial of Zephyr Endobronchial Valve Treatment in Heterogeneous Emphysema (LIBERATE).
    Criner GJ; Sue R; Wright S; Dransfield M; Rivas-Perez H; Wiese T; Sciurba FC; Shah PL; Wahidi MM; de Oliveira HG; Morrissey B; Cardoso PFG; Hays S; Majid A; Pastis N; Kopas L; Vollenweider M; McFadden PM; Machuzak M; Hsia DW; Sung A; Jarad N; Kornaszewska M; Hazelrigg S; Krishna G; Armstrong B; Shargill NS; Slebos DJ;
    Am J Respir Crit Care Med; 2018 Nov; 198(9):1151-1164. PubMed ID: 29787288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.